期刊文献+

养血强筋膏联合蠲痹汤治疗肝肾亏虚型膝骨关节炎的疗效及对VAS、HSS评分的影响 被引量:4

下载PDF
导出
摘要 目的:观察养血强筋膏联合蠲痹汤治疗肝肾亏虚型膝骨关节炎的临床疗效。方法:选择郑州市第一人民医院骨科收治的肝肾亏虚型膝骨关节炎患者96例,按1∶1的比例随机分为两组。对照组48例给予蠲痹汤(独活、羌活、秦艽、桂心、桑枝、海风藤、川芎、当归、乳香、木香、甘草片),水煎至400 mL,分2次服用,1剂/d,连续服用12周。治疗组在对照组的治疗基础上给予养血强筋膏基础方(生薏苡仁、阿胶、党参、生黄芪、生白术、熟地黄、当归、牛膝、炒白芍、赤芍、天花粉、菟丝子、黄精、旱莲草、玉竹、麦冬、姜黄、刘寄奴、三棱、莪术、制乳香、制没药、丹参、王不留行、羌活、牡丹皮、生地黄、独活、防风、陈皮、鳖甲、龟板、血竭)加减,每次15 mL,2次/d,早晚开水冲服。每4周服用1剂,共3剂。两组均连续服用12周后判定疗效。结果:治疗组痊愈17例,显效17例,有效13例,无效1例,有效率为97.92%(47/48);对照组痊愈10例,显效18例,有效7例,无效13例,有效率为72.92%(35/48)。两组对比,差异有统计学意义(P<0.05)。在中医证候积分、视觉模拟量表(VAS)评分、白细胞介素(IL)-1β、IL-6、基质金属蛋白酶-3(MMP-3)、肿瘤坏死因子-α(TNF-α)水平、美国特种外科医院(HSS)评分水平方面对比,治疗组治疗后优于对照组(P<0.01)。结论:养血强筋膏联合蠲痹汤治疗肝肾亏虚型膝骨关节炎疗效确切。
出处 《中医研究》 2022年第11期37-41,共5页 Traditional Chinese Medicinal Research
基金 河南省中医药科学研究专项课题(2019ZY2055)。
  • 相关文献

参考文献12

二级参考文献147

  • 1刘健,郭雯,程华威,黄传兵.类风湿性关节炎血清补体水平相关因素分析[J].中国临床保健杂志,2006,9(1):11-13. 被引量:21
  • 2Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum, 2000, 43: 1905-1915.
  • 3Schnitzer TJ, American College of Rheumatology. Update of ACR guidelines for osteoarthritis: role of the coxibs. J Pain Symptom Manage, 2002, 23(4 Suppl): S24-34.
  • 4Hochberg MC, Ahman RD, Brandt KD, et al. Guidelines for the medical management of osteoarthritis. Part Ⅱ. Osteoarthritis of the knee. American College of Rheumatology. Arthritis Rheum, 1995, 38:1541-1546.
  • 5Hochberg MC, Ahman RD, Brandt KD, et al. Guidelines for the medical management of osteoarthritis. Part Ⅰ. Osteoarthritis of the hip. American College of Rheumatology. Arthritis Rheum, 1995, 38: 1535-1540.
  • 6Simon LS, Lipman AG, Jacox AK, eds. Pain in osteoarthritis, rheumatoid arthritis and juvenile chronic arthritis. 2nd ed. Glenview (IL): American Pain Society (APS), 2002. 179.
  • 7Zhang W, Doherty M, Leeb BF, et al. EULAR evidence based recommendations for the management of hand osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis, 2007, 66: 377-388.
  • 8Zhang W, Doherty M. EULAR recommendations for knee and hip osteoarthritis: a critique of the methodology. Br J Sports Med, 2006, 40: 664-669.
  • 9Pendleton A, Arden N, Dougados M, et al. EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis, 2000, 59: 936-944.
  • 10Zhang W, Doherty M, Arden N, et al. EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis, 2005, 64: 669-681.

共引文献2119

同被引文献50

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部